Jung JK - Search Results

1

Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.

Park SH, Kim ND, Jung JK, Lee CK, Han SB, Kim Y. Park SH, et al. Among authors: jung jk. Pharmacol Ther. 2012 Mar;133(3):291-8. doi: 10.1016/j.pharmthera.2011.11.001. Epub 2011 Nov 19. Pharmacol Ther. 2012. PMID: 22119168 Review.

2

Cobrotoxin inhibits NF-kappa B activation and target gene expression through reaction with NF-kappa B signal molecules.

Park MH, Song HS, Kim KH, Son DJ, Lee SH, Yoon DY, Kim Y, Park IY, Song S, Hwang BY, Jung JK, Hong JT. Park MH, et al. Among authors: jung jk. Biochemistry. 2005 Jun 14;44(23):8326-36. doi: 10.1021/bi050156h. Biochemistry. 2005. PMID: 15938622

3

Structure-activity relationships of 6-hydroxy-7-methoxychroman-2-carboxylic acid N-(substituted)phenylamides as inhibitors of nuclear factor-kappaB activation.

Kwak JH, Kim BH, Jung JK, Kim Y, Cho J, Lee H. Kwak JH, et al. Among authors: jung jk. Arch Pharm Res. 2007 Oct;30(10):1210-5. doi: 10.1007/BF02980261. Arch Pharm Res. 2007. PMID: 18038899

4

Synthesis of chroman-2-carboxylic acid N-(substituted)phenylamides and their inhibitory effect on nuclear factor-kappaB (NF-kappaB) activation.

Kwak JH, Won SW, Kim TJ, Roh E, Kang HY, Lee HW, Jung JK, Hwang BY, Kim Y, Cho J, Lee H. Kwak JH, et al. Among authors: jung jk. Arch Pharm Res. 2008 Feb;31(2):133-41. doi: 10.1007/s12272-001-1131-4. Arch Pharm Res. 2008. PMID: 18365680

5

Synthesis and nuclear factor-kappaB inhibitory activities of 6- or 7-methylchroman-2-carboxylic acid N-(substituted) phenylamides.

Kwak JH, Won SW, Kim TJ, Yi W, Choi EH, Kim SC, Park H, Roh E, Jung JK, Hwang BY, Hong JT, Kim Y, Cho J, Lee H. Kwak JH, et al. Among authors: jung jk. Arch Pharm Res. 2009 Feb;32(2):167-75. doi: 10.1007/s12272-009-1131-3. Epub 2009 Mar 13. Arch Pharm Res. 2009. PMID: 19280144

6

Naphthoquinones from Catalpa ovata and their inhibitory effects on the production of nitric oxide.

Park BM, Hong SS, Lee C, Lee MS, Kang SJ, Shin YS, Jung JK, Hong JT, Kim Y, Lee MK, Hwang BY. Park BM, et al. Among authors: jung jk. Arch Pharm Res. 2010 Mar;33(3):381-5. doi: 10.1007/s12272-010-0306-2. Epub 2010 Mar 30. Arch Pharm Res. 2010. PMID: 20361302

7

Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones.

Kwak JH, Namgoong K, Jung JK, Han SB, Cho J, Kim HM, Park SG, Lee K, Kang JS, Lee H. Kwak JH, et al. Among authors: jung jk. Arch Pharm Res. 2010 May;33(5):663-7. doi: 10.1007/s12272-010-0503-z. Epub 2010 May 29. Arch Pharm Res. 2010. PMID: 20512462

8

Structure-activity relationship of indoline-2-carboxylic acid N-(substituted)phenylamide derivatives.

Kwak JH, Kim Y, Park H, Jang JY, Lee KK, Yi W, Kwak JA, Park SG, Kim H, Lee K, Kang JS, Han SB, Hwang BY, Hong JT, Jung JK, Kim Y, Cho J, Lee H. Kwak JH, et al. Among authors: jung jk. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4620-3. doi: 10.1016/j.bmcl.2010.06.004. Epub 2010 Jun 8. Bioorg Med Chem Lett. 2010. PMID: 20579876

9

Pyrrolidinone diterpenoid from Isodon excisus and inhibition of nitric oxide production in lipopolysaccharide-induced macrophage RAW264.7 cells.

Hong SS, Lee SA, Kim N, Hwang JS, Han XH, Lee MK, Jung JK, Hong JT, Kim Y, Lee D, Hwang BY. Hong SS, et al. Among authors: jung jk. Bioorg Med Chem Lett. 2011 Feb 15;21(4):1279-81. doi: 10.1016/j.bmcl.2010.11.095. Epub 2010 Nov 25. Bioorg Med Chem Lett. 2011. PMID: 21273070

10

Therapeutic applications of compounds in the Magnolia family.

Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT. Lee YJ, et al. Among authors: jung jk. Pharmacol Ther. 2011 May;130(2):157-76. doi: 10.1016/j.pharmthera.2011.01.010. Epub 2011 Jan 26. Pharmacol Ther. 2011. PMID: 21277893 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page